Novel therapeutic strategies for neuroendocrine tumours--can eminence replace evidence?

Acta Oncol. 2008;47(1):3-4. doi: 10.1080/02841860701630275.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Digestive System Neoplasms / drug therapy*
  • Digestive System Neoplasms / radiotherapy
  • Evidence-Based Medicine*
  • Humans
  • Neuroendocrine Tumors / drug therapy*
  • Neuroendocrine Tumors / radiotherapy
  • Octreotide / therapeutic use
  • Peptides, Cyclic / therapeutic use
  • Radioisotopes / therapeutic use*
  • Receptors, Somatostatin / drug effects
  • Somatostatin / analogs & derivatives
  • Somatostatin / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Peptides, Cyclic
  • Radioisotopes
  • Receptors, Somatostatin
  • lanreotide
  • Somatostatin
  • Octreotide